Virbac SA Overview
Pro stress-test →Virbac is a French company dedicated to animal health located in Carros, near Nice. The company is the 6th largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024 (62% companion animal and 38% food producing animal). The company serves a global customer base including veterinarians, farmers, and pet owners across multiple continents.
Strategic Profile
Pro stress-test →Virbac manufactures and sells a range of products and services for companion and farm animals globally, offering vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. In 2024, Virbac's revenue was 1.40 billion, an increase of 12.07% compared to the previous year's 1.25 billion.
Competitive Landscape
Pro stress-test →Virbac is one of the 10 biggest veterinary pharmaceutical companies in the world. The company competes in the fragmented animal health sector alongside multinational pharma players with veterinary divisions and specialized animal health companies. Strong regional presence in Europe and Latin America provides competitive advantage alongside global scale competitors.
Industry Context
Virbac SA operates in Veterinary Pharmaceuticals & Animal Health.
Key facts
Founded: 1968 · Headquarters: Carros, France · Revenue: $1.40B · Market cap: $3.62B